Delivery Order SPE2DB20D1047-SPE2DB25FF82P
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,264.50 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) with a firm fixed price arrangement. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,255.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The delivery order, which represents a child contract action under a larger vehicle, is scheduled for completion by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $2,905.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menquadfi vial 0.5mL, a meningococcal vaccine. The contract, which is not set aside and was competitively awarded, calls for ultimate completion by August 14, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine medical procurement action supporting federal...
- The Defense Logistics Agency awarded a $2,823.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,452.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen will perform work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,579.74 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial (0.5mL) under a firm fixed price, non-set-aside contract. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,905.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Menquadfi vial 0.5 mL on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded contract, which involves no set-aside designation, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical product fulfillment under the federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The contract is valued at $2,179.32 with a firm fixed price structure and an ultimate completion date of July 30, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- On July 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. The delivery order is a...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF82PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,401.45 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's portfolio includes extensive deliveries of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for Menquadfi—a meningococcal vaccine—aligns with the company's demonstrated capability to supply vaccines and critical medical products to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/10/25 |